Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Allergan and Biogen Gain Ground in Financial Market Stocks

By AP | June 1, 2016

NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday:

Allergan PLC, down 19 cents to $235.75

Billionaire investor Carl Icahn said he recently bought a “large” stake in the Botox maker.

Westar Energy Inc., up $3.41 to $56.33

The biggest utility company in Kansas agreed to be bought by Great Plains Energy for $60 per share, or $8.5 billion.

Clorox Co., down $1.16 to $128.54

Companies that make household goods and foods traded lower following mixed reports about consumer behavior in the U.S.

Boeing Co., down $3.07 to $126.15

The U.S. Air Force announced new delays for Boeing’s KC-46 Pegasus Tanker, a midair refueling plane.

Celator Pharmaceuticals Inc., up $12.55 to $30.88

The cancer drug developer agreed to be bought by Jazz Pharmaceuticals for $30.25 per share, or $1.28 billion.

Biogen Inc., up $6.94 to $289.73

The Food and Drug Administration approved Biogen’s drug Zinbryta, a once-a-month injection for multiple sclerosis.

Coca-Cola European Partners PLC, up $1.76 to $38.81

The company was officially formed Tuesday when Coca-Cola Enterprises combined with two other European Coca-Cola bottling companies.

Medtronic PLC, down $1.21 to $80.48

The medical device maker reported solid first-quarter results but its guidance was a bit weaker than analysts expected.

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE